Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

6505--Famciclovir Tablets

Awarded
36E79726R0017Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of Veterans Affairs, through its National Acquisition Center, is awarding a single indefinite-delivery, indefinite-quantity contract for the supply of Famciclovir tablets in three strengths—125mg, 250mg, and 750mg—under NAICS code 325412. The contract has a one-year base period with four additional one-year options, potentially extending performance to five years, and will be awarded to one responsible offeror using FAR Part 12 commercial item procedures. Delivery is required to Government-contracted Prime Vendor distribution centers under F.O.B. Origin terms, with title passing upon delivery to the Prime Vendor. The procurement supports multiple federal agencies including VA, DoD, BOP, IHS, and FHCC, with estimated annual quantities of 1,012, 10,522, and 13,642 bottles respectively for each tablet strength across all years. All products must comply with FDA current Good Manufacturing Practices, USP-NF standards, and stringent barcoding requirements, including GS1-128, HIBCC, and UPC formats encoded with NDC in GTIN format, achieving a minimum ANSI/ISO/IEC Quality Grade C. Labeling must include lot number and expiration date, with human-readable elements adjacent to barcodes, and packaging must ensure integrity through validated stability testing. The contract includes mandatory clauses on whistleblower protections, System for Award Management registration, restrictions on subcontractor sales, small business utilization, and subcontracting plans with VA-specific deviations. Contractors must be registered in SAM, provide a UEI and CAGE Code, and comply with DSCSA requirements including two-dimensional GS1 Data Matrix codes on the lowest saleable package. Proposals are due electronically by April 6, 2026, to designated VA email addresses, with no physical submissions permitted. The Government will conduct all inspection and acceptance at the delivery point, and payment will follow Prompt Payment Act guidelines. A small business subcontracting plan is required, and offers must include representations regarding size status and socioeconomic certifications. The contract prohibits organizational conflicts of interest and requires compliance with federal procurement integrity, lobbying restrictions, and labor standards. While pricing is not disclosed in the solicitation, contractors must adhere to Federal Ceiling Price rules and a 0.5% cost recovery fee. No contract value is stated, and no evaluation factors, weights, or award method are specified, indicating a potential best-value or lowest-price technically acceptable approach

General Info

VA seeks vendor for Famciclovir Tablets in three dosages, one base year plus four option years.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Awardee

AVKARE LLCView Profile

Award Issued Date

Documents

(4)

Amendment 0001 to Solicitation 36E79726R0017 - Extension of Offer Due Date

DOCXamendment

36E79726D0036.docx

DOCX

RFP 36E79726R0017 for Famciclovir Tablets

DOCX3 pagespresolicitation

Solicitation 36E79726R0017 for Famciclovir Tablets

DOCXrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Amendment 1

Contract was updated

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
View Agency Profile
Office AddressHINES, IL, 60141, USA
Contacts
Richard MaharioContract Specialist

Full Description

Show more
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=381f9adfaa9748f68041d45209d15afc

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Ticagrelor Tablets
Solicitation # 36E79726R0028
The Department of Veterans Affairs National Acquisition Center is seeking an unrestricted procurement to establish an uninterrupted source of supply for Ticagrelor Tablets. This firm-fixed-price, indefinite-delivery requirements contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The award is designated as a HUBZONE small business set-aside and will be granted to the lowest-priced, technically acceptable offeror. The contract structure consists of a base year and four one-year options, with a maximum 60-calendar day implementation period before the ordering period begins. The scope of work includes the supply of Ticagrelor in 60mg and 90mg strengths across various bottle sizes, ranging from 60 to 1,000 tablets. Strict packaging and labeling standards are required, including the use of cylindrical bottles with a minimum 120cc volume and 5.75 inch circumference, safety caps that are convertible or deshelled, and unique 11-digit NDC numbers. All products must be compatible with automated dispensing units and feature GS1-128 or HIBC linear bar codes, as well as two-dimensional data matrix bar codes per the Drug Supply Chain Security Act. To be eligible for award, offerors must maintain an acceptable FDA cGMP status for their manufacturing facilities and provide the necessary NDA, ANDA, or BLA clearances. Those who are not the manufacturer must provide a formal Letter of Commitment ensuring a sufficient source of supply. Distribution will be managed through Government Prime Vendor contracts, with deliveries made to approximately 56 VA and DoD distribution centers nationwide. Proposals must be submitted in PDF or Word format, including a signed SF-1449 and pricing for all line items across the base and option years, with prices held firm for 120 calendar days.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
Federal
6505--2027-2028 Influenza Virus Vaccine
Solicitation # 36E79726R0035
Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.
Pharmaceutical Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 11 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS